Stay updated with breaking news from Device Designation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SCD's ability to improve clinical status of four critically ill pediatric and adult patients across multiple clinical conditions published in Transpl
Click Therapeutics, Inc. ("Click"), a leader in Digital Therapeuticstm as prescription medical treatments, today announced plans to accelerate its development initiatives in obesity and cardiometabolic disease through the acquisition of the assets of...
Click Therapeutics, a leader in prescription digital therapeutics (DTx), announced the acquisition of key assets from Better Therapeutics.
A lipoprotein (a) (Lp[a]) assay has been granted breakthrough device designation to expand identification of patients with elevated Lp(a) and genetic predispositions to cardiovascular disease.